The Company’s 7.75% Senior Subordinated Notes due 2020, 3.75% Convertible Senior Subordinated Notes due 2025 and the 3.75% Convertible Senior Subordinated Notes due 2042 are fully and unconditionally guaranteed, subject to certain customary release provisions, on an unsecured, joint and several basis by certain wholly-owned subsidiaries of the Company (the “Guarantor Subsidiaries”). The following condensed consolidating unaudited financial data illustrates the composition of Omnicare, Inc. (“Parent”), the Guarantor Subsidiaries and the non-guarantor Subsidiaries as of June 30, 2013 and December 31, 2012 for the balance sheets, as well as the three and six months ended June 30, 2013 and 2012 for the statements of comprehensive income and the statements of cash flows for the six months ended June 30, 2013 and 2012. Management believes separate complete financial statements of the Guarantor Subsidiaries would not provide information that would be necessary for evaluating the sufficiency of the Guarantor Subsidiaries, and thus are not presented. The equity method has been used with respect to the Parent company’s investment in subsidiaries. No consolidating/eliminating adjustment column is presented for the condensed consolidating statements of cash flows since there were no significant consolidating/eliminating adjustment amounts during the periods presented.

Summary Consolidating

Statements of Comprehensive Income

(in thousands)



	For the three months ended June 30,
2013:	Parent			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating / Eliminating Adjustments			Omnicare, Inc. and Subsidiaries
Net sales	$	—		$	1,536,702		$	33,195		$	—		$	1,569,897
Cost of sales	—			1,172,210			19,237			—			1,191,447
Gross profit	—			364,492			13,958			—			378,450
Selling, general and administrative expenses	1,186			196,944			5,558			—			203,688
Provision for doubtful accounts	—			24,856			490			—			25,346
Settlement, litigation and other related charges	—			3,512			—			—			3,512
Other charges	—			31,268			—			—			31,268
Operating income (loss)	(1,186		)	107,912			7,910			—			114,636
Interest expense, net of investment income	(29,183		)	(253		)	(188		)	—			(29,624		)
Income (loss) before income taxes	(30,369		)	107,659			7,722			—			85,012
Income tax (benefit) expense	(11,659		)	41,488			2,964			—			32,793
Equity of net income of subsidiaries	70,929			—			—			(70,929		)	—
Net income	$	52,219		$	66,171		$	4,758		$	(70,929	)	$	52,219
Comprehensive income	$	52,145		$	66,171		$	4,758		$	(70,929	)	$	52,145
2012:
Net sales	$	—		$	1,501,324		$	34,703		$	—		$	1,536,027
Cost of sales	—			1,146,567			22,114			—			1,168,681
Gross profit	—			354,757			12,589			—			367,346
Selling, general and administrative expenses	1,119			194,618			6,141			—			201,878
Provision for doubtful accounts	—			23,619			459			—			24,078
Settlement, litigation and other related charges	—			26,093			—			—			26,093
Other charges	35,092			14,117			—			—			49,209
Operating income (loss)	(36,211		)	96,310			5,989			—			66,088
Interest expense, net of investment income	(35,133		)	(255		)	(186		)	—			(35,574		)
Income (loss) before income taxes	(71,344		)	96,055			5,803			—			30,514
Income tax (benefit) expense	(27,570		)	37,152			2,240			—			11,822
Equity of net income of subsidiaries	62,466			—			—			(62,466		)	—
Net income (loss)	$	18,692		$	58,903		$	3,563		$	(62,466	)	$	18,692
Comprehensive income	$	17,003		$	58,903		$	1,876		$	(60,779	)	$	17,003

Note 9 - Guarantor Subsidiaries (Continued)

Summary Consolidating

Statements of Comprehensive Income

(in thousands)



	For the six months ended June 30,
2013:	Parent			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Consolidating / Eliminating Adjustments			Omnicare, Inc. and Subsidiaries
Net sales	$	—		$	3,029,090		$	65,810		$	—		$	3,094,900
Cost of sales	—			2,307,550			38,076			—			2,345,626
Gross profit	—			721,540			27,734			—			749,274
Selling, general and administrative expenses	2,192			392,980			10,342			—			405,514
Provision for doubtful accounts	—			48,602			970			—			49,572
Settlement, litigation and other related charges	—			26,131			—			—			26,131
Other charges	—			35,274			—			—			35,274
Operating income (loss)	(2,192		)	218,553			16,422			—			232,783
Interest expense, net of investment income	(58,174		)	(543		)	(366		)	—			(59,083		)
Income (loss) before income taxes	(60,366		)	218,010			16,056			—			173,700
Income tax (benefit) expense	(23,205		)	84,160			6,172			—			67,127
Equity of net income of subsidiaries	143,734			—			—			(143,734		)	—
Net income	$	106,573		$	133,850		$	9,884		$	(143,734	)	$	106,573
Comprehensive income	$	106,475		$	133,850		$	9,884		$	(143,734	)	$	106,475
2012:
Net sales	$	—		$	3,058,727		$	70,368		$	—		$	3,129,095
Cost of sales	—			2,347,716			45,933			—			2,393,649
Gross profit	—			711,011			24,435			—			735,446
Selling, general and administrative expenses	2,122			383,341			16,539			—			402,002
Provision for doubtful accounts	—			47,585			924			—			48,509
Settlement, litigation and other related charges	—			33,296			—			—			33,296
Other charges	35,092			25,629			—			—			60,721
Operating income (loss)	(37,214		)	221,160			6,972			—			190,918
Interest expense, net of investment income	(65,521		)	(538		)	(349		)	—			(66,408		)
Income (loss) from continuing operations before income taxes	(102,735		)	220,622			6,623			—			124,510
Income tax (benefit) expense	(39,656		)	84,907			4,828			—			50,079
Equity of net income of subsidiaries	137,510			—			—			(137,510		)	—
Net income	$	74,431		$	135,715		$	1,795		$	(137,510	)	$	74,431
Comprehensive income	$	73,164		$	135,715		$	1,252		$	(136,967	)	$	73,164

Note 9 - Guarantor Subsidiaries (Continued)

Condensed Consolidating Balance Sheets

(in thousands)



As of June 30, 2013:	Parent		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Consolidating/Eliminating Adjustments			Omnicare, Inc. and Subsidiaries
ASSETS
Cash and cash equivalents	$	479,460	$	45,337	$	10,563	$	—		$	535,360
Restricted cash	—		5		—		—			5
Accounts receivable, net (including intercompany)	—		758,129		306,615		(300,296		)	764,448
Inventories	—		394,751		7,379		—			402,130
Deferred income tax benefits, net-current	—		97,902		—		(286		)	97,616
Other current assets	1,796		284,182		21,441		(10,825		)	296,594
Total current assets	481,256		1,580,306		345,998		(311,407		)	2,096,153
Properties and equipment, net	—		295,380		6,574		—			301,954
Goodwill	—		4,224,637		28,824		—			4,253,461
Identifiable intangible assets, net	—		172,756		2,597		—			175,353
Other noncurrent assets	48,235		71,309		3,264		(8,194		)	114,614
Investment in subsidiaries	5,351,140		—		—		(5,351,140		)	—
Total assets	$	5,880,631	$	6,344,388	$	387,257	$	(5,670,741	)	$	6,941,535
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities	$	466,287	$	668,899	$	39,709	$	(311,121	)	$	863,774
Long-term debt, notes and convertible debentures	1,574,589		16,935		5,000		(5,000		)	1,591,524
Deferred income tax liabilities	341,892		570,530		15,157		(286		)	927,293
Other noncurrent liabilities			64,275		—		(3,194		)	61,081
Stockholders' equity	3,497,863		5,023,749		327,391		(5,351,140		)	3,497,863
Total liabilities and stockholders' equity	$	5,880,631	$	6,344,388	$	387,257	$	(5,670,741	)	$	6,941,535
As of December 31, 2012:
ASSETS
Cash and cash equivalents	$	383,674	$	58,312	$	12,227	$	—		$	454,213
Restricted cash	—		1,066		—		—			1,066
Accounts receivable, net (including intercompany)	—		849,753		197,370		(190,071		)	857,052
Inventories	—		379,448		6,250		—			385,698
Deferred income tax benefits, net-current	—		137,736		—		(1,550		)	136,186
Other current assets	1,765		248,833		14,871		(10,825		)	254,644
Total current assets	385,439		1,675,148		230,718		(202,446		)	2,088,859
Properties and equipment, net	—		276,056		6,604		—			282,660
Goodwill	—		4,219,900		37,059		—			4,256,959
Identifiable intangible assets, net	—		193,852		3,021		—			196,873
Other noncurrent assets	75,336		93,508		11,382		(16,313		)	163,913
Investment in subsidiaries	5,453,702		—		—		(5,453,702		)	—
Total assets	$	5,914,477	$	6,458,464	$	288,784	$	(5,672,461	)	$	6,989,264

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities	$	60,454	$	587,025	$	35,431	$	(200,896	)	$	482,014
Long-term debt, notes and convertible debentures	2,012,807		17,223		5,000		(5,000		)	2,030,030
Deferred income tax liabilities	335,504		559,405		21,301		(1,550		)	914,660
Other noncurrent liabilities	—		68,161		—		(11,313		)	56,848
Stockholders' equity	3,505,712		5,226,650		227,052		(5,453,702		)	3,505,712
Total liabilities and stockholders' equity	$	5,914,477	$	6,458,464	$	288,784	$	(5,672,461	)	$	6,989,264

Note 9 - Guarantor Subsidiaries (Continued)

Condensed Consolidating Statements of Cash Flows

(in thousands)



	Six months ended June 30,
2013:	Parent			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Omnicare, Inc. and Subsidiaries
Cash flows from operating activities:
Net cash flows (used in) from operating activities	$	(11,358	)	$	275,143		$	(1,116	)	$	262,669
Cash flows from investing activities:
Acquisition of businesses, net of cash received	—			(298		)	—			(298		)
Disposition of businesses	—			675			—			675
Capital expenditures	—			(46,289		)	(548		)	(46,837		)
Other	(227		)	852			—			625
Net cash flows used in investing activities	(227		)	(45,060		)	(548		)	(45,835		)
Cash flows from financing activities:
Payments on terms loans	(10,626		)	—			—			(10,626		)
Payments on long-term borrowings and obligations	(3,434		)	—			—			(3,434		)
Capped call transaction	(38		)	—			—			(38		)
Increase (decrease) in cash overdraft balance	(10,324		)	91			—			(10,233		)
Payments for Omnicare common stock repurchase	(100,302		)	—			—			(100,302		)
Dividends paid	(28,766		)	—			—			(28,766		)
Other	260,861			(243,149		)	—			17,712
Net cash flows from (used in) financing activities	107,371			(243,058		)	—			(135,687		)
Net increase (decrease) in cash and cash equivalents	95,786			(12,975		)	(1,664		)	81,147
Cash and cash equivalents at beginning of period	383,674			58,312			12,227			454,213
Cash and cash equivalents at end of period	$	479,460		$	45,337		$	10,563		$	535,360
2012:
Cash flows from operating activities:
Net cash flows (used in) from operating activities	$	(42,150	)	$	260,896		$	1,869		$	220,615
Cash flows from investing activities:
Acquisition of businesses, net of cash received	—			(568		)	—			(568		)
Divestiture of business, net	—			—			—			—
Capital expenditures	—			(45,290		)	(1,145		)	(46,435		)
Other	—			(1,085		)	499			(586		)
Net cash flows used in investing activities	—			(46,943		)	(646		)	(47,589		)
Cash flows from financing activities:
Payments on term loans	(11,250		)	—			—			(11,250		)
Payments on long-term borrowings and obligations	(26,046		)	—			—			(26,046		)
Capped call transaction	(48,126		)	—			—			(48,126		)
Increase (decrease) in cash overdraft balance	497			(7,815		)	—			(7,318		)
Payments for Omnicare common stock repurchases	(80,307		)	—			—			(80,307		)
Dividends paid	(15,521		)	—			—			(15,521		)
Other	207,887			(207,888		)	(240		)	(241		)
Net cash flows from (used in) financing activities	27,134			(215,703		)	(240		)	(188,809		)
Net increase (decrease) in cash and cash equivalents	(15,016		)	(1,750		)	983			(15,783		)
Cash and cash equivalents at beginning of period	460,253			101,786			18,223			580,262
Cash and cash equivalents at end of period	$	445,237		$	100,036		$	19,206		$	564,479

Note 9 - Guarantor Subsidiaries (Continued)

The Company’s 3.25% convertible senior debentures due 2035 (with optional redemption by Omnicare on or after, or an optional repurchase right of holders on, December 15, 2015, at par) are fully and unconditionally guaranteed, subject to certain customary release provisions, on an unsecured basis by Omnicare Purchasing Company, LP, a wholly-owned subsidiary of the Company (the “Guarantor Subsidiary”). The following condensed consolidating unaudited financial data illustrates the composition of Omnicare, Inc. (“Parent”), the Guarantor Subsidiary and the non-guarantor Subsidiaries as of June 30, 2013 and December 31, 2012 for the balance sheets, as well as the three and six months ended June 30, 2013 and 2012 for the statements of comprehensive income and the statements of cash flows for the six months ended June 30, 2013 and 2012. Management believes separate complete financial statements of the Guarantor Subsidiary would not provide information that would be necessary for evaluating the sufficiency of the Guarantor Subsidiary, and thus are not presented. The Guarantor Subsidiary does not have any material net cash flows in the condensed consolidating statements of cash flows. The equity method has been used with respect to the Parent company’s investment in subsidiaries. No consolidating/eliminating adjustments column is presented for the condensed consolidating statements of cash flows since there were no significant consolidating/eliminating adjustment amounts during the periods presented.

Summary Consolidating

Statements of Comprehensive Income

(in thousands)



	For the three months ended June 30,
2013:	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries			Consolidating / Eliminating Adjustments			Omnicare, Inc. and Subsidiaries
Net sales	$	—		$	—		$	1,569,897		$	—		$	1,569,897
Cost of sales	—			—			1,191,447			—			1,191,447
Gross profit	—			—			378,450			—			378,450
Selling, general and administrative expenses	1,186			417			202,085			—			203,688
Provision for doubtful accounts	—			—			25,346			—			25,346
Settlement, litigation and other related charges	—			—			3,512			—			3,512
Other charges	—			—			31,268			—			31,268
Operating income (loss)	(1,186		)	(417		)	116,239			—			114,636
Interest expense, net of investment income	(29,183		)	—			(441		)	—			(29,624		)
Income (loss) before income taxes	(30,369		)	(417		)	115,798			—			85,012
Income tax (benefit) expense	(11,659		)	(160		)	44,612			—			32,793
Equity of net income of subsidiaries	70,929			—			—			(70,929		)	—
Net income (loss)	$	52,219		$	(257	)	$	71,186		$	(70,929	)	$	52,219
Comprehensive income (loss)	$	52,145		$	(257	)	$	71,186		$	(70,929	)	$	52,145
2012:
Net sales	$	—		$	—		$	1,536,027		$	—		$	1,536,027
Cost of sales	—			—			1,168,681			—			1,168,681
Gross profit	—			—			367,346			—			367,346
Selling, general and administrative expenses	1,119			346			200,413			—			201,878
Provision for doubtful accounts	—			—			24,078			—			24,078
Settlement, litigation and other related charges	—			—			26,093			—			26,093
Other charges	35,092			—			14,117			—			49,209
Operating income (loss)	(36,211		)	(346		)	102,645			—			66,088
Interest expense, net of investment income	(35,133		)	—			(441		)	—			(35,574		)
Income (loss) before income taxes	(71,344		)	(346		)	102,204			—			30,514
Income tax (benefit) expense	(27,570		)	(134		)	39,526			—			11,822
Equity of net income of subsidiaries	62,466			—			—			(62,466		)	—
Net income (loss)	$	18,692		$	(212	)	$	62,678		$	(62,466	)	$	18,692
Comprehensive income (loss)	$	17,003		$	(212	)	$	60,991		$	(60,779	)	$	17,003

Note 9 - Guarantor Subsidiaries (Continued)

Summary Consolidating

Statements of Comprehensive Income

(in thousands)



	For the six months ended June 30,
2013:	Parent			Guarantor Subsidiary			Non-Guarantor Subsidiaries			Consolidating / Eliminating Adjustments			Omnicare, Inc. and Subsidiaries
Net sales	$	—		$	—		$	3,094,900		$	—		$	3,094,900
Cost of sales	—			—			2,345,626			—			2,345,626
Gross profit	—			—			749,274			—			749,274
Selling, general and administrative expenses	2,192			816			402,506			—			405,514
Provision for doubtful accounts	—			—			49,572			—			49,572
Settlement, litigation and other related charges	—			—			26,131			—			26,131
Other charges	—			—			35,274			—			35,274
Operating income (loss)	(2,192		)	(816		)	235,791			—			232,783
Interest expense, net of investment income	(58,174		)	—			(909		)	—			(59,083		)
Income (loss) before income taxes	(60,366		)	(816		)	234,882			—			173,700
Income tax (benefit) expense	(23,205		)	(314		)	90,646			—			67,127
Equity of net income of subsidiaries	143,734			—			—			(143,734		)	—
Net income (loss)	$	106,573		$	(502	)	$	144,236		$	(143,734	)	$	106,573
Comprehensive income (loss)	$	106,475		$	(502	)	$	144,236		$	(143,734	)	$	106,475
2012:
Net sales	$	—		$	—		$	3,129,095		$	—		$	3,129,095
Cost of sales	—			—			2,393,649			—			2,393,649
Gross profit	—			—			735,446			—			735,446
Selling, general and administrative expenses	2,122			668			399,212			—			402,002
Provision for doubtful accounts	—			—			48,509			—			48,509
Settlement, litigation and other related charges	—			—			33,296			—			33,296
Other charges	35,092			—			25,629			—			60,721
Operating income (loss)	(37,214		)	(668		)	228,800			—			190,918
Interest expense, net of investment income	(65,521		)	—			(887		)	—			(66,408		)
Income (loss) before income taxes	(102,735		)	(668		)	227,913			—			124,510
Income tax (benefit) expense	(39,656		)	(258		)	89,993			—			50,079
Equity of net income of subsidiaries	137,510			—			—			(137,510		)	—
Net income (loss)	$	74,431		$	(410	)	$	137,920		$	(137,510	)	74,431
Comprehensive income (loss)	$	73,164		$	(410	)	$	137,377		$	(136,967	)	$	73,164

Note 9 - Guarantor Subsidiaries (Continued)

Condensed Consolidating Balance Sheets

(in thousands)



As of June 30, 2013:	Parent		Guarantor Subsidiary		Non-Guarantor Subsidiaries		Consolidating/Eliminating Adjustments			Omnicare, Inc. and Subsidiaries
ASSETS
Cash and cash equivalents	$	479,460	$	—	$	55,900	$	—		$	535,360
Restricted cash	—		—		5		—			5
Accounts receivable, net (including intercompany)	—		178		764,448		(178		)	764,448
Inventories	—		—		402,130		—			402,130
Deferred income tax benefits, net-current	—		—		97,616		—			97,616
Other current assets	1,796		—		294,798		—			296,594
Total current assets	481,256		178		1,614,897		(178		)	2,096,153
Properties and equipment, net	—		22		301,932		—			301,954
Goodwill	—		—		4,253,461		—			4,253,461
Identifiable intangible assets, net	—		—		175,353		—			175,353
Other noncurrent assets	48,235		19		66,360		—			114,614
Investment in subsidiaries	5,351,140		—		—		(5,351,140		)	—
Total assets	$	5,880,631	$	219	$	6,412,003	$	(5,351,318	)	$	6,941,535
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities	$	466,287	$	—	$	397,665	$	(178	)	$	863,774
Long-term debt, notes and convertible debentures	1,574,589		—		16,935		—			1,591,524
Deferred income tax liabilities	341,892		—		585,401		—			927,293
Other noncurrent liabilities			—		61,081		—			61,081
Stockholders' equity	3,497,863		219		5,350,921		(5,351,140		)	3,497,863
Total liabilities and stockholders' equity	$	5,880,631	$	219	$	6,412,003	$	(5,351,318	)	$	6,941,535
As of December 31, 2012:
ASSETS
Cash and cash equivalents	$	383,674	$	—	$	70,539	$	—		$	454,213
Restricted cash	—		—		1,066		—			1,066
Accounts receivable, net (including intercompany)	—		204		857,052		(204		)	857,052
Inventories	—		—		385,698		—			385,698
Deferred income tax benefits, net-current	—		—		137,736		(1,550		)	136,186
Other current assets	1,765		—		252,879		—			254,644
Total current assets	385,439		204		1,704,970		(1,754		)	2,088,859
Properties and equipment, net	—		22		282,638		—			282,660
Goodwill	—		—		4,256,959		—			4,256,959
Identifiable intangible assets, net	—		—		196,873		—			196,873
Other noncurrent assets	75,336		19		88,558		—			163,913
Investment in subsidiaries	5,453,702		—		—		(5,453,702		)	—
Total assets	$	5,914,477	$	245	$	6,529,998	$	(5,455,456	)	$	6,989,264
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities	$	60,454	$	54	$	421,710	$	(204	)	$	482,014
Long-term debt, notes and convertible debentures	2,012,807		—		17,223		—			2,030,030
Deferred income tax liabilities	335,504		—		580,706		(1,550		)	914,660
Other noncurrent liabilities	—		—		56,848		—			56,848
Stockholders' equity	3,505,712		191		5,453,511		(5,453,702		)	3,505,712
Total liabilities and stockholders' equity	$	5,914,477	$	245	$	6,529,998	$	(5,455,456	)	$	6,989,264

Note 9 - Guarantor Subsidiaries (Continued)

Condensed Consolidating Statements of Cash Flows - Unaudited

(in thousands)



	Six months ended June 30,
2013:	Parent			Guarantor Subsidiary		Non-Guarantor Subsidiaries			Omnicare, Inc. and Subsidiaries
Cash flows from operating activities:
Net cash flows (used in) from operating activities	$	(11,358	)	$	—	$	274,027		$	262,669
Cash flows from investing activities:
Acquisition of businesses, net of cash received	—			—		(298		)	(298		)
Disposition of businesses	—			—		675			675
Capital expenditures	—			—		(46,837		)	(46,837		)
Other	(227		)	—		852			625
Net cash flows used in investing activities	(227		)	—		(45,608		)	(45,835		)
Cash flows from financing activities:
Payments on terms loans	(10,626		)	—		—			(10,626		)
Payments on long-term borrowings and obligations	(3,434		)	—		—			(3,434		)
Capped call transaction	(38		)	—		—			(38		)
Increase (decrease) in cash overdraft balance	(10,324		)	—		91			(10,233		)
Payments for Omnicare common stock repurchase	(100,302		)	—		—			(100,302		)
Dividends paid	(28,766		)	—		—			(28,766		)
Other	260,861			—		(243,149		)	17,712
Net cash flows from (used in) financing activities	107,371			—		(243,058		)	(135,687		)
Net increase (decrease) in cash and cash equivalents	95,786			—		(14,639		)	81,147
Cash and cash equivalents at beginning of period	383,674			—		70,539			454,213
Cash and cash equivalents at end of period	$	479,460		$	—	$	55,900		$	535,360
2012:
Cash flows from operating activities:
Net cash flows (used in) from operating activities	$	(42,150	)	$	—	$	262,765		$	220,615
Cash flows from investing activities:
Acquisition of businesses, net of cash received	—			—		(568		)	(568		)
Divestiture of business, net	—			—		—			—
Capital expenditures	—			—		(46,435		)	(46,435		)
Other	—			—		(586		)	(586		)
Net cash flows used in investing activities	—			—		(47,589		)	(47,589		)
Cash flows from financing activities:
Payments on term loans	(11,250		)	—		—			(11,250		)
Payments on long-term borrowings and obligations	(26,046		)	—		—			(26,046		)
Capped call transaction	(48,126		)	—		—			(48,126		)
Increase (decrease) in cash overdraft balance	497			—		(7,815		)	(7,318		)
Payments for Omnicare common stock repurchases	(80,307		)	—		—			(80,307		)
Dividends paid	(15,521		)	—		—			(15,521		)
Other	207,887			—		(208,128		)	(241		)
Net cash flows from (used in) financing activities	27,134			—		(215,943		)	(188,809		)
Net decrease in cash and cash equivalents	(15,016		)	—		(767		)	(15,783		)
Cash and cash equivalents at beginning of period	460,253			—		120,009			580,262
Cash and cash equivalents at end of period	$	445,237		$	—	$	119,242		$	564,479